Amifostine Market is gigantic to Grow at a high CAGR 2.2% over the forecast period 2019 and 2025 | Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical

The report is a must-have for business strategists, participants, consultants, researchers, investors, entrepreneurs, and other interested parties associated with the global Amifostine market. It is also a highly useful resource for those looking to foray into the global Amifostine Market. Besides Porter’s Five Forces and SWOT analysis, it offers detailed value chain assessment, comprehensive study on market dynamics including drivers, restraints, and opportunities, recent trends, and industry performance analysis. Furthermore, it digs deep into critical aspects of key subjects such as market competition, regional growth, and market segmentation so that readers could gain sound understanding of the global Amifostinemarket.

The global Amifostine market is valued at 48 million US$ in 2018 is expected to reach 57 million US$ by the end of 2025, growing at a CAGR of 2.2% during 2019-2025.

Key Players: Clinigen Group, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma, Mingren Pharma

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/949197/global-amifostine-market

Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.

Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.

The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen Group, Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen Group acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China.

Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep upward tendency and to be worthy of 49.99 million USD in 2023 globally.

Type Segments: 400mg/Dose, 500mg/Dose

Application Segments: Head and Neck Cancer Adjuvant Therapy, Others

Global Amifostine Market: Regional Segmentation

For a deeper understanding, the research report includes geographical segmentation of the global Amifostine market. It provides an evaluation of the volatility of the political scenarios and amends likely to be made to the regulatory structures. This assessment gives an accurate analysis of the regional-wise growth of the global Amifostine market.

The Middle East and Africa (GCC Countries and Egypt)

North America (the United States, Mexico, and Canada)

South America (Brazil etc.)

Europe (Turkey, Germany, Russia UK, Italy, France, etc.)

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Global Amifostine Market: Research Methodology
The research methodologies used by the analysts play an integral role in the way the publication has been collated. Analysts have used primary and secondary research methodologies to create a comprehensive analysis. For an accurate and precise analysis of the global Amifostine market, analysts have bottom-up and top-down approaches.

Global Amifostine Market: Competitive Rivalry

The research report includes an analysis of the competitive landscape present in the global Amifostine market. It includes an assessment of the existing and upcoming trends that players can invest in. Furthermore, it also includes an evaluation of the financial outlooks of the players and explains the nature of the competition.

Get Customized Report in your Inbox within 24 hours: https://www.qyresearch.com/customize-request/form/949197/global-amifostine-market

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Amifostine market

Chapter 2: Evaluating the leading manufacturers of the global Amifostine market which consists of its revenue, sales, and price of the products

Chapter 3: Displaying the competitive nature among key manufacturers, with Amifostine market share, revenue, and sales

Chapter 4: Presenting global Amifostine market by regions, market share and with revenue and sales for the projected period

Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions

Contact us,
QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA 91748
USA: +1 6264 288 800
India: +91 9766 478 224
Emails: enquiry@qyresearch.com
Web: www.qyresearch.com

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

This release was published on openPR.